These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37713940)

  • 21. On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy.
    Svolos P; Tsougos I; Kyrgias G; Kappas C; Theodorou K
    Australas Phys Eng Sci Med; 2011 Apr; 34(1):69-81. PubMed ID: 21213098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers.
    Velker VM; Rodrigues GB; Dinniwell R; Hwee J; Louie AV
    Radiat Oncol; 2013 Jul; 8():188. PubMed ID: 23885662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy.
    Kindts I; Defraene G; Laenen A; Petillion S; Van Limbergen E; Depuydt T; Weltens C
    Acta Oncol; 2018 Jul; 57(7):916-923. PubMed ID: 29652212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal tissue complication probability of fibrosis in radiotherapy of breast cancer: accelerated partial breast irradiation vs conventional external-beam radiotherapy.
    Jothy Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
    J Cancer Res Ther; 2008; 4(3):126-30. PubMed ID: 18923205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The photon dose calculation algorithm used in breast radiotherapy has significant impact on the parameters of radiobiological models.
    Petillion S; Swinnen A; Defraene G; Verhoeven K; Weltens C; Van den Heuvel F
    J Appl Clin Med Phys; 2014 Jul; 15(4):259–269. PubMed ID: 25207416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of separate multi-atlases for auto segmentation of cardiac substructures in CT-scans acquired in deep inspiration breath hold and free breathing.
    Spoor DS; Sijtsema NM; van den Bogaard VAB; van der Schaaf A; Brouwer CL; Ta BDP; Vliegenthart R; Kierkels RGJ; Langendijk JA; Maduro JH; Peters FBJ; Crijns APG
    Radiother Oncol; 2021 Oct; 163():46-54. PubMed ID: 34343547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review of the normal tissue complication probability models and parameters: Head and neck cancers treated with conformal radiotherapy.
    Tajiki S; Joya M; Gharekhani V; Richeson D; Gholami S
    Head Neck; 2023 Dec; 45(12):3146-3156. PubMed ID: 37767820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 29. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
    D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
    Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
    Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
    Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery.
    Chung SY; Chang JS; Choi MS; Chang Y; Choi BS; Chun J; Keum KC; Kim JS; Kim YB
    Radiat Oncol; 2021 Feb; 16(1):44. PubMed ID: 33632248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
    Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
    Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy.
    Balagopal A; Nguyen D; Morgan H; Weng Y; Dohopolski M; Lin MH; Barkousaraie AS; Gonzalez Y; Garant A; Desai N; Hannan R; Jiang S
    Med Image Anal; 2021 Aug; 72():102101. PubMed ID: 34111573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans.
    Chaikh A; Calugaru V; Bondiau PY; Thariat J; Balosso J
    Int J Radiat Biol; 2018 Sep; 94(9):789-797. PubMed ID: 29878849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Urethra Sparing on Tumor Control Probability and Normal Tissue Complication Probability in Focal Dose Escalated Hypofractionated Radiotherapy: A Planning Study Based on Histopathology Reference.
    Spohn SKB; Sachpazidis I; Wiehle R; Thomann B; Sigle A; Bronsert P; Ruf J; Benndorf M; Nicolay NH; Sprave T; Grosu AL; Baltas D; Zamboglou C
    Front Oncol; 2021; 11():652678. PubMed ID: 34055621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patients.
    Nielsen CP; Lorenzen EL; Jensen K; Sarup N; Brink C; Smulders B; Holm AIS; Samsøe E; Nielsen MS; Sibolt P; Skyt PS; Elstrøm UV; Johansen J; Zukauskaite R; Eriksen JG; Farhadi M; Andersen M; Maare C; Overgaard J; Grau C; Friborg J; Hansen CR
    Acta Oncol; 2023 Nov; 62(11):1418-1425. PubMed ID: 37703300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
    Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
    Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-induced fibrosis in the boost area after three-dimensional conformal radiotherapy with a simultaneous integrated boost technique for early-stage breast cancer: A multivariable prediction model.
    Hammer C; Maduro JH; Bantema-Joppe EJ; van der Schaaf A; van der Laan HP; Langendijk JA; Crijns AP
    Radiother Oncol; 2017 Jan; 122(1):45-49. PubMed ID: 27793444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.